Fibanix Injection contains Tirofiban Hydrochloride 12.5 mg/250 ml, a non-peptide glycoprotein IIb/IIIa receptor inhibitor used as an antiplatelet agent. It helps prevent platelet aggregation and the formation of blood clots in patients with acute coronary conditions. This medicine is commonly used in hospital settings, especially in cardiology emergencies, under strict medical supervision.

Tirofiban is typically used alongside other antiplatelet and anticoagulant therapies to reduce the risk of heart attack or further ischemic complications.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Uses

Fibanix Injection is indicated for:

• Acute coronary syndrome (unstable angina)
• Non-ST elevation myocardial infarction (NSTEMI)
• Prevention of ischemic complications during percutaneous coronary intervention (PCI)
• High-risk cardiac patients requiring platelet inhibition
• Adjunct therapy with aspirin and heparin

Mechanism of Action

Tirofiban works by inhibiting platelet aggregation:

• Blocks glycoprotein IIb/IIIa receptors on platelets
• Prevents fibrinogen binding and platelet cross-linking
• Inhibits final common pathway of platelet aggregation
• Reduces formation of arterial thrombus
• Helps maintain blood flow in coronary arteries

Dosage & Administration

• Administered as an intravenous infusion in hospital settings
• Dose is calculated based on patient weight and clinical protocol
• Often given as a loading dose followed by continuous infusion
• Used in combination with other antiplatelet and anticoagulant drugs
• Continuous monitoring of bleeding risk is essential
• Must be administered by trained healthcare professionals only

Side Effects

Common side effects may include:

• Bleeding (gastrointestinal, injection site, or internal)
• Low platelet count (thrombocytopenia)
• Headache
• Nausea
• Dizziness
• Hypotension

Serious bleeding complications may occur and require immediate medical attention.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Contraindicated in active internal bleeding
• Use cautiously in patients with recent surgery or trauma
• Not recommended in history of hemorrhagic stroke
• Regular monitoring of platelet count is required
• Use only in hospital with emergency facilities
• Avoid concomitant use with other strong anticoagulants unless prescribed

Storage

• Store below 25°C in a cool and dry place
• Do not freeze
• Protect from light
• Keep in original packaging
• Keep out of reach of children.